June 25 (Reuters) - China's Sinovac Biotech said on Saturday that South Africa's health products regulator has granted conditional registration to its coronavirus vaccine CoronaVac for people aged 18 and above. (Reporting by Akanksha Khushi in Bengaluru; Editing by Sam Holmes)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.47 USD | -0.31% | -.--% | -.--% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,945 PTS | -0.01% | +2.09% | - | ||
445.1 PTS | -0.49% | -1.93% | - | ||
151.5 PTS | +0.11% | +0.09% | - | ||
1st Jan change | Capi. | |
---|---|---|
-.--% | 642M | |
-2.86% | 87.37B | |
+3.95% | 41.01B | |
-21.94% | 28.08B | |
+53.11% | 24.72B | |
-5.41% | 17.47B | |
-44.23% | 11.69B | |
-17.60% | 11.6B | |
-13.96% | 11.56B | |
-0.22% | 8.44B |
- Stock Market
- Equities
- SVA Stock
- News Sinovac Biotech Ltd.
- Sinovac's COVID-19 vaccine conditionally registered in South Africa